Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Naltrexone for Dry Eye in Diabetic Subjects
NCT03660475Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dry eye disease (DED) comparing Naltrexone with Placebo (2 arms). Primary endpoint: Total Ocular Surface Disease Index at Day 29. Started Jul 2018; status: completed.
02
Drugs
naltrexone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03660475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03660475.